RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Financials
  4. Stockholders' equity

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.5B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 20241,541+90.00%
Dec 31, 2023811-26.33%
Dec 31, 20221,101-14.80%
Dec 31, 20211,292+223.40%
Dec 31, 2020400-37.63%
Dec 31, 2019641-6.84%
Dec 31, 2018688+83.10%
Dec 31, 2017376+4.72%
Dec 31, 2016359+3.90%
Dec 31, 2015345-18.67%
Dec 31, 2014424+222.76%
Dec 31, 2013131

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)